In addition to their support role in neurotransmitter and ion buffering, astrocytes directly regulate neurotransmission at synapses via local bidirectional signaling with neurons.
Introduction
The functional role of astrocytes is not limited to buffering extracellular ions and neurotransmitters, but also includes an active involvement in neurotransmission.
Astrocytes interact with neurons by responding to neurotransmitters and by releasing gliotransmitters 1 . However, the neuron-astrocyte interaction has been largely limited to the tripartite synapse, or neuronal pre-and postsynaptic elements and surrounding astrocyte (Araque et al., 1999; Halassa et al., 2007) . Astrocytic calcium signals can be transmitted through branched astrocyte arbors (Cornell-Bell et al., 1990; Charles et al., 1991; Porter and McCarthy, 1996) or can be localized to subdomains within branches (Haustein et al., 2014; Shigetomi et al., 2013) , giving astrocytes the potential to signal remotely from the response generation site, and electrical coupling via gap junctions extends this capacity beyond the limits of the astrocytic arbor 9 . Whether astrocytes transmit neuron-derived signals distally is currently not known. Kock et al., 2003) . We reported that vasopressin released from vasopressin neuron dendrites activates a calcium signal in astrocytes that leads to stimulation of presynaptic GABA neurons (Haam et al., 2014) .
The hypothalamic-pituitary-adrenal (HPA) axis comprises the neuroendocrine stress response, producing systemic glucocorticoid secretion from the adrenals following corticotropin-releasing factor (CRF) secretion from the hypothalamic paraventricular nucleus (PVN) and adrenocorticotrophic hormone secretion from the pituitary. Brainstem noradrenergic systems provide a major excitatory drive to the HPA axis. Anatomical and physiological studies indicate that CRF neurons receive direct noradrenergic innervation (Itoi et al., 1994; Plotsky, 1987 Here, we investigated the cellular mechanisms of the norepinephrine excitation of CRF neurons using whole-cell recordings in brain slices. We found that norepinephrine elicits the dendritic release of vasopressin from the CRF neurons to activate an astrocytic relay to presynaptic glutamate and GABA neurons, revealing a previously unidentified astrocytic amplification of retrograde volume transmission.
Results

NE activation of CRF neurons
Extracellular loose-seal, cell-attached patch clamp recordings were performed in CRF neurons to record the spontaneous spiking activity. Bath application of norepinephrine (NE, 100 μM, 5 min) significantly increased the firing frequency of CRF-eGFP neurons (p < 0.01), which was suppressed in the glutamate receptor antagonists DNQX (15 μM) and AP5 (50 μM) (p = 0.37) and enhanced in picrotoxin (50 mM), though this did not reach significance (Two-way ANOVA, F (2, 33) = 3.522, p = 0.04, followed by Bonferroni's multiple comparisons) ( Fig. 1A-C ). To test whether the excitation of CRF neurons is mediated by NE modulation of synaptic inputs, we recorded spontaneous EPSCs (sEPSCs) and IPSCs (sIPSCs) in CRF neurons. sEPSCs had a basal mean frequency of 1.56 ± 0.10 Hz, amplitude of 19.13 ± 0.50 pA, and decay time of 2.18 ± 0.06 ms (n = 47); bath application of NE (100 μM, 5 min) evoked a robust increase in the frequency of sEPSCs (335.2 ± 61.5% of baseline at 100 μM, n = 17, p < 0.01), without causing a change in sEPSC amplitude (p = 0.14) or decay time (p = 0.58) ( Fig. 1D, E; Supplemental Fig. 2A ), which suggested a possible presynaptic site of action. The NE stimulation of excitatory synaptic inputs to CRF neurons was concentrationdependent, with a threshold concentration of ~100 nM (118.7 ± 7.99% of baseline, n = 9, p = 0.047) ( Fig. 1F ). It was also action potential-dependent, since blockade of voltagegated Na + channels with tetrodotoxin (TTX, 1 μM) abolished the NE-induced increase in sEPSC frequency (92.4 ± 9.0% of baseline, n = 9, p = 0.42) ( Fig. 1G ).
The sIPSCs in CRF-eGFP neurons had a basal mean frequency of 0.86 ± 0.10 Hz, amplitude of 51.23±3.82 pA, and decay time of 12.72 ± 0.54 ms (n = 20). Norepinephrine (100 μM, 5 min) induced two distinct effects on sIPSCs in separate cohorts of CRF neurons: 55% of CRF neurons (11/20) showed a ~75% increase in sIPSC frequency (p < 0.01) and 45% (9/20) showed a ~50% decrease in sIPSC frequency (p < 0.01) ( Fig. 1H, I) , with no effect on sIPSC amplitude (p = 0.53) or decay time (p = 0.12) ( Supplementary   Fig. 2B ). The NE-induced increase in sIPSC frequency was not seen in any CRF neurons recorded in the presence of TTX, and all of the cells showed a decrease in the sIPSC frequency (65.14% ± 2.78%, n = 8, p < 0.01) ( Fig. 1J ). Thus, the NE facilitation of inhibitory synaptic inputs to CRF neurons is action potential-dependent, while the NEinduced suppression of inhibitory synaptic inputs is action potential-independent. The facilitatory effect of 100-μM NE on GABA release in some cells, therefore, masked the NE-induced suppression of GABA release, which occurred in all CRF neurons tested.
The absence of the spike-dependent facilitatory response in some CRF neurons suggested that the axons of the NE-sensitive presynaptic neurons were cut in those slices.
The two effects of NE on synaptic inhibition had different concentration sensitivities. Nearly all the CRF neurons (14/16 cells) responded to NE with either no response or a suppression of sIPSCs at the lowest concentrations tested (100 nM and 1 μM), and the proportion of cells that responded with a facilitation of sIPSCs increased at higher NE concentrations (2/9 cells (22%) at 10 μM and 11/20 cells (55%) at 100 μM) ( Fig. 1K ). Thus, the spike-dependent NE facilitation of GABA release had a higher threshold (~10 μM) than the spike-independent NE suppression of GABA release (< 100 nM). Note that the threshold for facilitation of excitatory synaptic inputs (~100 nM) was over an order of magnitude lower than the threshold for NE facilitation of inhibitory synaptic inputs to the CRF neurons. Additionally, the NE activation of inhibitory synaptic inputs was less robust than the activation of excitatory synaptic inputs, which accounts for the net excitatory effect of NE on the CRF neuron spiking. In recordings of sIPSCs in the presence of DNQX and AP5, bath application of the α 1 adrenoreceptor antagonist prazosin (10 μM) alone caused a significant decrease in the sIPSC frequency compared to baseline (81.82% ± 6.33% of baseline, n = 8, p = 0.02), again suggesting a tonic activation of α 1 -adrenoceptors and modulation of GABA release by endogenous NE. Norepinephrine (100 μM) failed to elicit an increase in sIPSC frequency following preapplication of prazosin, but all 8 CRF neurons recorded in prazosin responded with a significant decrease in sIPSC frequency (36.31% ± 5.01% of baseline, n = 8, p < 0.01) ( Fig. 2D , E). This indicated that the NE facilitation of IPSCs, like the facilitation of EPSCs, is mediated by α 1 -adrenoreceptor activation, whereas the NE-induced suppression of IPSCs is α1-receptor independent. The NE-induced suppression of sIPSCs was greater in the presence of prazosin (51% of baseline without prazosin vs. 36% of baseline with prazosin) and this difference showed a strong trend towards significance (p=0.050) ( Fig. 2E) , which supports a model of opposing NE regulation of GABA release onto CRF neurons.
Because the NE facilitation, but not suppression, of GABA release was spikedependent, we blocked the facilitatory response with TTX (1 μM) to isolate the NEinduced suppression of GABA release. In the presence of TTX, preapplication of the α 2 adrenoreceptor antagonist yohimbine (20 μM) alone had no effect on sIPSC frequency, but completely blocked the NE-induced decrease in sIPSC frequency (103.8% ± 10.57%, n = 8, p = 0.86) ( Fig. 2F, G) . Thus, at lower concentrations, NE activates presynaptic α 2 adrenoreceptors to suppress GABA release and, at higher concentrations, it also activates α 1 adrenoreceptors to stimulate spiking in presynaptic GABA neurons and an increase in GABA release onto PVN CRF neurons.
Localization of adrenoreceptors to pre-and postsynaptic loci
Our data suggest that NE causes a spike-dependent increase in excitatory and inhibitory synaptic inputs to PVN CRF neurons by acting at α1 adrenoreceptors on local presynaptic glutamate and GABA neurons, respectively. However, considerable immunohistochemical evidence exists for noradrenergic synapses directly on CRF neurons (Flak et al., 2009; Liposits et al., 1986) and for α 1 -adrenoceptor expression by CRF neurons 34 . Here, we tested for the dependence of the NE effect on the activation of postsynaptic receptors by including a broad-spectrum G-protein inhibitor, GDP-β-S (1 mM), in the patch electrode. The NE-induced increase in sEPSC frequency was blocked in 7 of 10 CRF neurons (70%) recorded with GDP-β-S-containing electrodes (123.4 ± 36.6% of baseline, n = 10, p = 0.54) ( Fig. 3A, B ), which suggested that the α 1 adrenoceptor-induced facilitation of excitatory synaptic inputs to the CRF neurons has a postsynaptic locus. With GDP-β-S in the patch solution and glutamate receptors blocked, only 15% of CRF neurons (2/13) responded to NE (100 μM) with an increase in sIPSC frequency, while 85% of CRF neurons (11/13) responded with a decrease in sIPSC frequency (71.53% ± 10.92% of baseline, n = 13, p = 0.023) ( Fig. 3C, D) . The shift in the distribution of the two sIPSC responses caused by postsynaptic G-protein blockade (increase: 55% without GDP-βs to 15% with GDP-βs; decrease: 45% without GDP-βs to 85% with GDP-βs) was significant (p = 0.023, chi-squared). This suggested that the NEinduced facilitation of GABA release, like that of glutamate release, is dependent on postsynaptic G protein activation, whereas the NE-induced suppression of GABA release is not. Therefore, the NE facilitation of excitatory and inhibitory synaptic inputs to CRF neurons share a common mechanism: postsynaptic α 1 receptor activation that results in spike generation in presynaptic glutamate and GABA neurons. The NE-induced suppression of inhibitory synaptic inputs to the CRF neurons, on the other hand, is 1 0 mediated by the activation of presynaptic α 2 adrenoreceptors and is spike-independent, indicating that it occurs at presynaptic GABA terminals. The reliance of the NE facilitation of glutamate and GABA inputs on a postsynaptic G protein-dependent mechanism suggests the recruitment of a retrograde signaling mechanism in this effect.
The norepinephrine-induced facilitation of excitatory and inhibitory synaptic inputs to CRF neurons is mediated by dendritic vasopressin release
The activation of presynaptic glutamate and GABA neurons by a postsynaptic α 1 adrenoreceptor-dependent mechanism implicates the dendritic release of an excitatory retrograde messenger. We tested for the involvement of nitric oxide (NO) and CRF, but the NE effect was not dependent on either signal ( Supplementary Fig. 3 ). Vasopressin is expressed in CRF neurons and released from CRF neuron axon terminals in the median eminence in response to different stressors and central α 1 -adrenoreceptor activation (Whitnall et al., 1993; de Goeij et al., 1991) . We showed recently that vasopressin is released as a retrograde messenger from the dendrites of magnocellular vasopressinergic neurons in the PVN and activates a retrograde signaling mechanism that increases spikedependent GABAergic inputs to the vasopressin neurons 37 . Therefore, we tested for the vasopressin dependence of the NE-induced facilitation of sEPSCs. While without effect on basal sEPSCs (p = 0.42), bath application of the vasopressin V1a receptor antagonist SR 49059 completely blocked the increase in sEPSC frequency induced by 100 μM NE (104.5% ± 17.07% of baseline, n = 6, p = 0.80) ( Fig. 3E ). We then tested for an agonistic effect of vasopressin on sEPSC frequency with pressure application of vasopressin (20 μM) on the surface of the slices close to the recorded CRF neurons (8-20 psi, 30 s).
Vasopressin caused a robust increase in the sEPSC frequency in CRF neurons (221.9% ± 36.56%, n = 6, p = 0.021) ( Fig. 3E ), which was not significantly different from the NEinduced increase in sEPSC frequency. These two experiments suggested that vasopressin is the messenger that is released in response to NE and that activates presynaptic glutamate neurons. However, the release of vasopressin from CRF neuron dendrites has not been described before and is unexpected, so we tested whether the source of vasopressin was from neighboring vasopressin neurons in the PVN. In our previous study, we found that ghrelin elicits the dendritic release of vasopressin from vasopressin neurons in the PVN, resulting in an increase in TTX-sensitive synaptic inputs to the vasopressin neurons 37 . Bath application of ghrelin (100 nM) had no effect on the sEPSCs recorded in CRF neurons (frequency: 104.5% ± 11.54% of baseline, n = 10, p = 0.71) ( Supplementary Fig. 3B ), which excluded vasopressin neurons as the source of intra-PVN vasopressin and suggested that the V1a receptor-dependent NE response was mediated by vasopressin release from CRF neurons.
The norepinephrine facilitation of excitatory and inhibitory inputs to CRF neurons is dependent on astrocyte activity and gliotransmission
The spike dependence of the retrograde facilitation of excitatory and inhibitory synaptic inputs to the CRF neurons suggests that the dendritic messenger acts at a distal presynaptic somatic/dendritic locus to excite presynaptic glutamate and GABA neurons.
We tested for a role of astrocytes as intermediates in the relay of the retrograde signal responsible for the NE-induced activation of presynaptic excitatory and inhibitory neurons. Fluorocitric acid (FCA) is preferentially taken up by glia and reversibly blocks glial metabolic function by impairing the Krebs cycle (Paulsen et al., 1987; Swanson and Graham, 1994) , which inhibits glial signaling. Preincubation of slices in FCA (100 µM) for 2-4 h prior to recordings significantly blunted the NE-induced increase in sEPSC frequency (144.33% ± 16.23%, n = 13, p = 0.018 compared to baseline, p < 0.01 compared to NE effect in untreated slices) ( Fig 4A, B) . Preincubation of slices in FCA also blocked the NE-induced increase in sIPSC frequency, resulting in a decrease in sIPSC frequency (74.74% ± 7.78% compared to baseline, n = 10, p = 0.01) ( Fig. 4C, D) .
This suggested that the NE-induced facilitation of both excitatory and inhibitory synaptic inputs to CRF neurons is dependent on astrocyte activity.
We next tested whether the NE-induced increase in sEPSC and sIPSC frequencies is dependent on the release of the gliotransmitter ATP by blocking purinergic receptors.
Bath application of PPADS (100 µM), a non-selective P2 receptor antagonist, blocked the NE-induced increase in sEPSC frequency (120.8 ± 37.7% of baseline, n = 7, p = 0.42; NE vs. NE/PPADS: p = 0.04) ( Fig 4E) . In recordings of sIPSCs, bath application of TNP-ATP (10 μM), a selective P 2 X purinergic receptor antagonist, blocked the NE-induced increase in sIPSC frequency, sparing the NE-induced decrease in sIPSC frequency (41.89% ± 3.57%, n = 6, p < 0.01) (Fig. 4F ). The P 2 X antagonist had no effect on the NE-induced decrease in sIPSC frequency (NE vs. TNP-ATP/NE: p = 0.12) ( Fig. 4F) , which was consistent with the NE-induced suppression of GABA release not being dependent on the retrograde signaling mechanism. Thus, the NE-induced facilitation of excitatory and inhibitory synaptic inputs to the CRF neurons depends on the ATP activation of P 2 X purinergic receptors.
To further test for the glial participation in the NE-induced facilitation of excitatory and inhibitory synaptic inputs, we next conducted calcium imaging experiments using the glia-specific calcium indicator Rhod-2 AM 40 to examine whether NE causes a calcium response in glial cells. Slices were incubated in Rhod-2 AM (1-3 μM) for 30-60 minutes to bulk load the calcium fluorophore. Norepinephrine (100 μM, 5 min) induced a significant increase in the relative fluorescence intensity (116.4% ± 3.88%, n = 30, p<0.01), which was blocked with a non-selective oxytocin and vasopressin receptor antagonist, Manning compound (kindly provided by Professor
Maurice Manning, University of Toledo) ( Fig. 4G, I ). We did not use the selective V1a receptor antagonist here because it induced autofluorescence in the brain slices. We next tested whether vasopressin activates a calcium response in astrocytes. Bath application of vasopressin (200 nM) also caused an increase in the relative fluorescence signal (154.7% ± 14.38%, n = 9, p < 0.01) ( Fig. 4H, I) . These results together suggest that NE stimulates presynaptic glutamate and GABA circuits by activating PVN astrocytes via a vasopressin V1a receptor-dependent mechanism.
The recruitment of glia into the retrograde signaling mechanism triggered by NE and the involvement of ATP as a gliotransmitter in the activation of presynaptic glutamate and GABA neurons suggested that ATP may be released from astrocytes by exocytosis. We tested this hypothesis using a transgenic mouse model (kindly provided Mice were taken off the doxycycline diet for 5 weeks to induce dnSNARE expression, and mice maintained on the doxycycline diet to suppress dnSNARE expression served as controls. The NE-induced increase in sEPSC frequency was maintained in CRF neurons from CRF-eGFP/dnSNARE mice kept on the doxycycline diet (on-dox/NE: 258.7% ± 60.85% compared to baseline, n = 6, p = 0.048; on-dox/NE vs. control/NE: p = 0.50). In slices from CRF-eGFP/dnSNARE mice taken off the doxycycline diet, the NE-induced increase in sEPSC frequency, although still significant compared to baseline (124.4% ± 7.27%, n = 7, p = 0.015), was significantly suppressed compared to the NE effect in slices from mice maintained on the doxycycline diet (off-dox/NE vs. on-dox/NE: p = 0.037) (Fig. 4J ). This suggested that the NE-induced facilitation of glutamate release onto CRF neurons is suppressed by blocking exocytosis in astrocytes.
Modulation of excitatory and inhibitory synaptic inputs to CRF neurons by endogenous norepinephrine
To determine whether endogenous NE release exerts a similar modulatory effect on excitatory and inhibitory synaptic inputs to PVN CRF neurons, we applied an optogenetic strategy to activate noradrenergic afferent inputs. An AAV9 expressing Credependent channelrhodopsin and mCherry was injected bilaterally into the nucleus of the solitary tract (NTS) of CRF-eGFP,TH-Cre mice. Following confirmation using confocal microscopy of mCherry expression in cell bodies of the NTS and in axon terminal fields in the PVN (Fig. 5A, B) , we tested for an excitatory synaptic response in CRF-eGFP neurons to photostimulation of the PVN with blue light (490 nm, 2 min continuous) to activate channelrhodopsin. CRF neurons responded to photostimulation with an increase in sEPSC frequency (355.4% ± 65.8%, n=12, p < 0.01) (Fig. 5C, D) , but not amplitude or decay (p = 0.99, 0.89, respectively). The increase in sEPSC frequency was significantly inhibited by the α 1 -adrenoreceptor antagonist prazosin (10 μM) (p = 0.041), but a significant EPSC frequency response to the photostimulation remained (243.4% ± 44.68%, n = 7, p = 0.018) (Fig. 5D) . Similarly, the increase in sEPSC frequency to photostimulation was significantly inhibited by blocking postsynaptic G protein activity in the recorded cells with GDP-β-S application (1 mM) via the patch pipette (p = 0.03), but the effect of photostimulation was not completely blocked, as a significant increase in sEPSC frequency remained (252.5% ± 35.15%, n = 6, p < 0.01) (Fig. 5D ). The α1
receptor-and G protein-independent response suggests that glutamate may be co-released from the activated noradrenergic afferents.
We also tested for the modulation of IPSCs by endogenous NE release in slices from CRF-eGFP,TH-cre mice following virally-mediated channelrhodopsin transduction in the NTS. In the presence of glutamate receptor antagonists, photostimulation failed to elicit a facilitation of sIPSCs, but caused a decrease in sIPSC frequency in all the cells tested (48.45% ± 3.95% of baseline, n = 6, p < 0.01) ( Fig. 5E, F ).
Discussion
We found that NE stimulates CRF neurons by a novel dendritic signaling mechanism that activates upstream presynaptic glutamate and GABA neurons via transmission through astrocytes, as shown in our model in Fig. 6 . The astrocyte participation in the retrograde signaling significantly expands the spatial domain of the signal to more distal targets than would be reached by dendritic volume transmission alone. This retrograde neuronal-glial signaling mechanism is novel because the signaling is not spatially restricted to the three components of the tripartite synapse, i.e., the presynaptic terminal, the postsynaptic dendrite, and the peri-synaptic astrocyte branch 41 .
This retrograde signaling spans a potentially significant distance to the presynaptic somata/dendrites of upstream glutamate and GABA neurons to drive action potential generation. Indeed, the spatial reach of the retrograde signal could attain even greater distances if the astrocytic calcium signal were transmitted to coupled astrocytes via gap junctions. This needs to be further studied, but could explain why we saw a less robust NE facilitation of inhibitory than excitatory synaptic inputs, since the presynaptic GABA GABAergic inputs compared to glutamatergic inputs is consistent with a higher threshold to activate the presynaptic GABA neurons. The component of the photostimulated response that was blocked by the α1 antagonist (~50%) (Fig. 5D ) suggests that the effective concentration of released NE was between 100 nM and 1 μM, which was subthreshold for the facilitatory effect of NE on GABA release (see Fig. 1 ).
We found converging lines of evidence for an astrocyte intermediate in the retrograde transmission to presynaptic glutamate and GABA neurons. First, both NE and vasopressin elicited calcium responses in astrocytes. Second, the NE facilitation of synaptic inputs to the CRF neurons was lost following pretreatment of brain slices with the gliotoxin FCA. Third, the NE responses were also lost in CRF neurons from transgenic mice in which exocytosis was conditionally suppressed in astrocytes. Finally, the NE responses were blocked by antagonists of the conventional gliotransmitter, ATP.
The sensitivity of the responses to the P2x receptor antagonists and to TTX, and their dependence on astrocytic exocytosis, suggest that astrocytic ATP release drives action potential generation in presynaptic glutamate and GABA neurons by activating purinergic receptors, consistent with our previous findings 37 . Thus, the evidence for the retrograde transmission to presynaptic glutamate and GABA neurons by way of one or more intercalated astrocytes is compelling.
A surprising discovery of this study was that the retrograde transmitter is vasopressin, which was indicated by the blockade of both the NE-induced synaptic response in CRF neurons and the calcium response in astrocytes by vasopressin receptor antagonists, but not by a CRFR1 antagonist or NO scavenger, and by a vasopressinevoked synaptic response in the CRF neurons and calcium response in astrocytes.
Astrocytes express vasopressin V1a receptors (Hatton et al., 1992; Yamazaki et al., 1997) and we showed previously that vasopressin generates a calcium response in PVN astrocytes 37 . The source of the vasopressin could have been from neighboring PVN vasopressin neurons, but this was ruled out because ghrelin, which stimulates vasopressin release from vasopressin neuron dendrites 37 , had no effect on sEPSCs in the CRF neurons. 
